Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-113,600
Closed -$1.67M 8409
2025
Q3
$1.67M Buy
113,600
+70,400
+163% +$718K ﹤0.01% 2501
2025
Q2
$424K Buy
43,200
+29,900
+225% +$248K ﹤0.01% 3584
2025
Q1
$96.7K Sell
13,300
-12,700
-49% -$111K ﹤0.01% 4628
2024
Q4
$203K Sell
26,000
-9,700
-27% -$79.9K ﹤0.01% 3923
2024
Q3
$264K Buy
35,700
+3,400
+11% +$28.6K ﹤0.01% 3376
2024
Q2
$259K Sell
32,300
-64,200
-67% -$573K ﹤0.01% 3180
2024
Q1
$1.12M Sell
96,500
-26,700
-22% -$296K ﹤0.01% 1986
2023
Q4
$1.38M Buy
123,200
+56,300
+84% +$517K ﹤0.01% 2163
2023
Q3
$1.03M Buy
66,900
+24,400
+57% +$410K ﹤0.01% 2232
2023
Q2
$805K Buy
42,500
+21,200
+100% +$372K ﹤0.01% 2558
2023
Q1
$324K Buy
21,300
+20,800
+4,160% +$271K ﹤0.01% 3185
2022
Q4
$6.37K Buy
500
+200
+67% +$1.8K ﹤0.01% 6233
2022
Q3
$2K Buy
+300
New +$1.32K ﹤0.01% 7138

Other funds holding ETNB

Group One Trading's ETNB Position: Q3 2025 in Review

Group One Trading sold out of 89bio (ETNB) in Q3 2025, closing a stake of 17,177 shares — an estimated $175K sold.

Group One Trading first reported a position in ETNB in Q3 2022 and held it in 12 quarters. The position peaked at $1.36M in Q3 2023. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Group One Trading reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 17,177 89bio shares in Q3 2025, an estimated $175K.
  • Group One Trading first reported a position in 89bio in Q3 2022 and held it in 12 quarters.
  • Group One Trading's 89bio position peaked at $1.36M in Q3 2023.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.